322014 VO Introduction to Evidence Based Pharmacy - M10 (2024W)
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: German
Lecturers
Classes (iCal) - next class is marked with N
- Wednesday 02.10. 16:45 - 18:15 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Thursday 03.10. 08:00 - 09:30 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Monday 07.10. 16:45 - 18:15 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Tuesday 08.10. 08:00 - 09:30 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Wednesday 09.10. 16:45 - 18:15 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Thursday 10.10. 08:00 - 09:30 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Monday 14.10. 16:45 - 18:15 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Tuesday 15.10. 08:00 - 09:30 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
-
Tuesday
29.10.
08:00 - 09:30
UZA2 Hörsaal 7 (Raum 2Z210) 2.OG
UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
Information
Aims, contents and method of the course
This lecture provides in-depth knowledge of evidence-based pharmacy, which enables students to make decisions in pharmaceutical care and counseling based on the application of the best possible evidence (clinical studies, therapy guidelines, pharmacovigilance).The knowledge acquired is used in the course “Interpretation of Clinical Studies” that accompanies the lecture. A positive completion of the lecture examination is therefore a prerequisite for participation in the exercise "Interpretation of clinical studies".This lecture is offered as a face-to-face event.
Assessment and permitted materials
-) Written exam
-) Mixed examination mode: open questions and "multiple choice" questions
-) Exam duration: 60 min
-) Mixed examination mode: open questions and "multiple choice" questions
-) Exam duration: 60 min
Minimum requirements and assessment criteria
-) Number of questions: 12 questions
-) Maximum number of points: 12 pointsFor a positive assessment, you must achieve at least 3.5 points in both examination parts: part 1 (Kampleitner) and part 2 (Kamyar).Clef: 12-11 (1), 10.75-10 (2), 9.75-8 (3), 7.75-7 (4), 6.75-0 (5)
-) Maximum number of points: 12 pointsFor a positive assessment, you must achieve at least 3.5 points in both examination parts: part 1 (Kampleitner) and part 2 (Kamyar).Clef: 12-11 (1), 10.75-10 (2), 9.75-8 (3), 7.75-7 (4), 6.75-0 (5)
Examination topics
Script for the lecture (online: Moodle)
Reading list
1. “Fundamentals of Clinical Trials”, Autoren: Lawrence M. Friedman, Curt D. Furberg, David DeMets;
2. “Designing Clinical Research”, Autoren: Dr. Stephen B Hulley, MD, MPH, Steven R Cummings, MD, Warren S Browner, MD
3. “Practical Guide to Clinical Data Management”, Third Edition, Autoren: Susanne Prokscha
4. Study Design and Statistical Analysis: A Practical Guide for Clinicians; Autor: Mitchell Katz
5. Erfolgreich wissenschaftlich Arbeiten in der Klinik; Evidence Based Medicine; Autoren: Müllner, Marcus
6. Planning and Analyzing Clinical Trials with Composite Endpoints; Autoren: Rauch, Geraldine, Schüler, Svenja, Kieser, Meinhard
2. “Designing Clinical Research”, Autoren: Dr. Stephen B Hulley, MD, MPH, Steven R Cummings, MD, Warren S Browner, MD
3. “Practical Guide to Clinical Data Management”, Third Edition, Autoren: Susanne Prokscha
4. Study Design and Statistical Analysis: A Practical Guide for Clinicians; Autor: Mitchell Katz
5. Erfolgreich wissenschaftlich Arbeiten in der Klinik; Evidence Based Medicine; Autoren: Müllner, Marcus
6. Planning and Analyzing Clinical Trials with Composite Endpoints; Autoren: Rauch, Geraldine, Schüler, Svenja, Kieser, Meinhard
Association in the course directory
A231, A232, MA14
Last modified: Fr 02.08.2024 09:26